Literature DB >> 6686365

Urinary excretion of urate in patients with calcium oxalate stone disease.

H G Tiselius, L Larsson.   

Abstract

The diurnal variation in excretion and concentration of urinary urate was studied in 31 patients with calcium oxalate stone disease. Urate excretion was highest during the day-time, decreased in the evening and was low during the night. Meal-related peaks were observed. The concentration of urate reached the highest levels during the morning hours and, attributable to a low pH in morning urine, most samples were at this time super-saturated with respect to uric acid. In addition, many urines appeared to be at high risk of exceeding the uric acid formation product. Concerning the ion-activity product of sodium urate, supersaturated samples were frequently found, but the risk of exceeding the formation product for sodium urate at a normal urate excretion was apparently low.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6686365     DOI: 10.1007/bf00256347

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  26 in total

1.  Sodium urate accelerates precipitation of calcium oxalate in vitro.

Authors:  F L Coe; R L Lawton; R B Goldstein; V Tembe
Journal:  Proc Soc Exp Biol Med       Date:  1975-09

2.  [Oxalate stones and hyperuricuria].

Authors:  R Hartung; M Bergmann
Journal:  Helv Chir Acta       Date:  1974

3.  Uricemia and urolithiasis.

Authors:  M J Smith; L D Hunt; J S King; W H Boyce
Journal:  J Urol       Date:  1969-05       Impact factor: 7.450

4.  Adsorption of heparin on sodium acid urate.

Authors:  B Finlayson; L Du Bois
Journal:  Clin Chim Acta       Date:  1978-03-01       Impact factor: 3.786

5.  A biochemical basis for grouping of patients with urolithiasis.

Authors:  H G Tiselius; L E Almgård; L Larsson; B Sörbo
Journal:  Eur Urol       Date:  1978       Impact factor: 20.096

6.  Uric acid disorders in patients with calcium stones.

Authors:  A Hodgkinson
Journal:  Br J Urol       Date:  1976-02

7.  Uric acid saturation in calcium nephrolithiasis.

Authors:  F L Coe; A L Strauss; V Tembe; S Le Dun
Journal:  Kidney Int       Date:  1980-05       Impact factor: 10.612

8.  Allopurinol in the recurrence prevention of calcium oxalate lithiasis.

Authors:  G Brien; C Bick
Journal:  Eur Urol       Date:  1977       Impact factor: 20.096

9.  Urate metabolism and renal calcium stone disease.

Authors:  B Fellström
Journal:  Scand J Urol Nephrol Suppl       Date:  1981

10.  Epitaxial considerations in urinary stone formation. I. The urate-oxalate-phosphate system.

Authors:  P G Koutsoukos; C Y Lam-Erwin; G H Nancollas
Journal:  Invest Urol       Date:  1980-09
View more
  4 in total

1.  Circadian Periodicity of Circulating Plasma Lipid Peroxides, Uric Acid and Ascorbic Acid in Renal Stone Formers.

Authors:  Rajeev Singh Kushwaha; R C Gupta; J P Sharma; Sumita Sharma; Raj Kumar Singh; Germaine Cornelissen
Journal:  Indian J Clin Biochem       Date:  2016-07-15

2.  Effects of different doses of alkaline citrate on urine composition and crystallization of calcium oxalate.

Authors:  C Berg; L Larsson; H G Tiselius
Journal:  Urol Res       Date:  1990

3.  Effects of sodium urate and uric acid crystals on the crystallization of calcium oxalate.

Authors:  H G Tiselius
Journal:  Urol Res       Date:  1984

4.  [Effect of an allopurinol/benzbromaron preparation on the composition of urine in a circadian course].

Authors:  A Hesse; W Schneeberger; W Vahlensieck
Journal:  Klin Wochenschr       Date:  1987-03-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.